Home › Compare › TKYVY vs ABBV
TKYVY yields 31.75% · ABBV yields 3.06%● Live data
📍 TKYVY pulled ahead of the other in Year 1
Combined, TKYVY + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TKYVY + ABBV for your $10,000?
Türkiye Vakiflar Bankasi Türk Anonim Ortakligi, together with its subsidiaries, provides corporate, commercial, small business, retail, and investment banking services in Turkey and internationally. It offers time and demand deposits, accumulating accounts, repos, spot loans, foreign currency indexed loans, consumer loans, automobile and housing loans, working capital loans, discounted bills, overdraft facilities, gold loans, foreign currency loans, Eximbank loans, pre-export loans, ECA covered financing, letters of guarantee, letters of credit, export factoring, acceptance credits, and draft facilities. The company also provides forfeiting, leasing, forwards, futures, salary payments, investment accounts, cheques, safety boxes, tax collections, bill payment, and payment order services, as well as insurance products. In addition, it offers foreign trade transactions, cash management, factoring, credit cards, investment products, leasing, and other banking products to its corporate, commercial, and retail customers. Further, the company provides small business banking services, including overdraft accounts, POS machines, credit cards, cheque books, TL and foreign currency deposits, Internet banking and call-center, debit card, and bill payment to enterprises in retail and service sectors. Additionally, it offers capital market transactions; issues capital market tools; purchases and sells marketable securities; and provides investment consultancy and portfolio management services, as well as invests in marketable debt and equity securities, and gold and other precious metals. As of December 31, 2021, the company operated a network of 936 branches in Turkey, as well as 4 foreign branches located in New York, Bahrain, Qatar, and Erbil. Türkiye Vakiflar Bankasi Türk Anonim Ortakligi was founded in 1954 and is headquartered in Istanbul, Turkey. Türkiye Vakiflar Bankasi Türk Anonim Ortakligi is a subsidiary of Ministry of Treasury and Finance.
Full TKYVY Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.